CTI BioPharma Corp.
CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhi…
Biotechnology
US, Seattle [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
CTI BioPharma Corp. can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDCTI BioPharma Corp. can't present revenue by segment
Get PRO Today
With PRO you can bypass the blur for the segment revenues of CTI BioPharma Corp..
If you want to see a demo, head over to the financial segments of AAPL